Evidence map›Paper›PMID 42423917›Full record

ArticleProbiotics and antimicrobial proteins2026

Phenotypic and Genomic Characterization of Paenibacillus polymyxa SABE1 as a Probiotic Candidate in European Sea Bass (Dicentrarchus labrax).

Nicolás Cabrera-Guerle, Mouna Jlidi, Jimena Bravo, Antonio Gómez-Mercader, Daniel Montero, Nicolás López-Guerrero, José Ramos-Vivas, Luis Monzón-Atienza, Félix Acosta

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nicolás Cabrera-GuerleGrupo de Investigación en Acuicultura (GIA), ECOAQUA Institute, University of Las Palmas de Gran Canaria, Muelle de Taliarte s/n, Las Palmas de Gran Canaria, 35214, Spain.
Mouna JlidiLaboratory of Microbial Biotechnology and Engineering Enzymes (LBMIE), Center of Biotechnology of Sfax (CBS), University of Sfax, Sfax, Tunisia.
Jimena BravoGrupo de Investigación en Acuicultura (GIA), ECOAQUA Institute, University of Las Palmas de Gran Canaria, Muelle de Taliarte s/n, Las Palmas de Gran Canaria, 35214, Spain.
Antonio Gómez-MercaderGrupo de Investigación en Acuicultura (GIA), ECOAQUA Institute, University of Las Palmas de Gran Canaria, Muelle de Taliarte s/n, Las Palmas de Gran Canaria, 35214, Spain.
Daniel MonteroGrupo de Investigación en Acuicultura (GIA), ECOAQUA Institute, University of Las Palmas de Gran Canaria, Muelle de Taliarte s/n, Las Palmas de Gran Canaria, 35214, Spain.
Nicolás López-GuerreroGrupo de Investigación en Acuicultura (GIA), ECOAQUA Institute, University of Las Palmas de Gran Canaria, Muelle de Taliarte s/n, Las Palmas de Gran Canaria, 35214, Spain.
José Ramos-VivasResearch Group BIONUC (Biotechnology of Nutraceuticals and Bioactive Compounds), Area of Microbiology, Department of Functional Biology, Universidad de Oviedo, Oviedo, Spain.
Luis Monzón-Atienza *Grupo de Investigación en Acuicultura (GIA), ECOAQUA Institute, University of Las Palmas de Gran Canaria, Muelle de Taliarte s/n, Las Palmas de Gran Canaria, 35214, Spain. luis.monzon@ulpgc.es.ORCID http://orcid.org/0000-0001-6783-5553
Félix Acosta *Grupo de Investigación en Acuicultura (GIA), ECOAQUA Institute, University of Las Palmas de Gran Canaria, Muelle de Taliarte s/n, Las Palmas de Gran Canaria, 35214, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the 21st century, the emergence of multidrug-resistant bacteria has become a major concern in human and animal health, promoting the search for sustainable alternatives to antibiotics in aquaculture. Among these, probiotics have shown promising potential to improve fish health and disease resistance. This study evaluates the probiotic potential of Paenibacillus polymyxa SABE1 for application in European seabass (Dicentrarchus labrax) aquaculture. Its functional properties were assessed through in vitro assays, a challenge test against Vibrio parahaemolyticus, and whole-genome sequencing to determine safety and potential risks. Results indicate that P. polymyxa SABE1 exhibits strong antimicrobial activity, adhesion capacity, digestive resilience, and no hemolytic or pathogenic traits. Notably, the challenge assay showed a survival rate of 56.67% in treated fish, confirming its protective effect. Genomic analysis further supported its safety, revealing no relevant antibiotic resistance or virulence factors. Overall, P. polymyxa SABE1 demonstrates strong potential as a safe and effective probiotic candidate, supporting its use as a sustainable alternative to antibiotics in aquaculture.

Indexed as

ChallengeEuropean SeabassPaenibacillusProbioticVibrio

Identifiers

PMID42423917

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.